FindTrial
Sign In

Registry to evaluate 6 month optical coherence tomography findings after coronary implantation with BioMime sirolimus eluting stent

Registry to evaluate 6 month optical coherence tomography findings after coronary implantation with BioMime sirolimus eluting stent

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003316
Enrollment
30
Registered
2018-11-02
Start date
2017-01-17
Completion date
Unknown
Last updated
2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients 19-80 years 2. Patients who will treat with drug-eluting stent less than 24 mm for de novo lesions. 3. Patients with reference vessel with 2.5-3.5 mm

Exclusion criteria

Exclusion criteria: 1. Patients with acute coronary syndrome 2. Pateints with left main, chronic total occlusion, severe calcification, tortuous or cardiogenic shock 3. Patients contraindicated or hypersensitivity to sirolimus, stainless steel, heparin, antiplatelelet agents, or contrast agent 4. Patients with pregnancy or willing to be pregnant 5. Patients who do not give consent for this study protocol

Design outcomes

Primary

MeasureTime frame
The percentage of uncoevered strut by optical coherence tomography—

Secondary

MeasureTime frame
Not applicabe—

Countries

Korea, Republic of

Contacts

Public ContactSungjin Hong

Yonsei University Health System, Severance Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026